Ryeqo Европейски съюз - норвежки - EMA (European Medicines Agency)

ryeqo

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyomer - hypofysiske og hypotalamiske hormoner og analoger - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.

Ryeqo Норвегия - норвежки - Statens legemiddelverk

ryeqo

2care4 aps - relugoliks / Østradiolhemihydrat / noretisteronacetat - tablett, filmdrasjert - 40 mg / 1 mg / 0.5 mg

Ryeqo Норвегия - норвежки - Statens legemiddelverk

ryeqo

orifarm as - relugoliks / Østradiolhemihydrat / noretisteronacetat - tablett, filmdrasjert - 40 mg / 1 mg / 0.5 mg

Fampyra Европейски съюз - норвежки - EMA (European Medicines Agency)

fampyra

biogen netherlands b.v.  - fampridine - multippel sklerose - andre nervesystemet narkotika - fampyra angis for forbedring av gåing i voksen pasienter med multippel sklerose innen funksjonshemming (utvidet funksjonshemming status skala 4-7).

Fampridine Accord Европейски съюз - норвежки - EMA (European Medicines Agency)

fampridine accord

accord healthcare s.l.u. - fampridine - multippel sklerose - andre nervesystemet narkotika - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).